Cencora | COR - Sales Revenues

Stock Price
310.76
Daily Change
2.57 0.83%
Monthly
0.27%
Yearly
8.00%
Q2 Forecast
301.59

Cencora reported $85.93B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Ambu A/S DKK 1.56B 90M Dec/2025
Amplifon EUR 652M 88.7M Dec/2025
Apollo Hospitals Enterprise Ltd INR 64.77B 1.73B Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Brookdale Senior Living USD 754.09M 59.07M Dec/2025
Cencora USD 85.93B 32.02M Dec/2025
Coloplast 7.04B 83M Dec/2025
Convatec Group USD 1.26B 80M Dec/2025
Diasorin EUR 295M 15M Dec/2025
Encompass Health USD 1.54B 60M Dec/2025
Enovis USD 575.7M 26.8M Dec/2025
GE HealthCare Technologies USD 5.7B 555M Dec/2025
Gulf Medical Proj AED 213.77M 25.43M Dec/2025
Hoya 244.7B 10.21B Dec/2025
Med Life RON 787.96M 8.36M Sep/2025
Oriola-kd EUR 502M 38.7M Dec/2025
Pediatrix Medical Group USD 493.77M 896K Dec/2025
Rede D'or Sao Luiz BRL 14.38B 220M Dec/2025
Siemens Healthineers EUR 5.4B 920M Dec/2025
Solventum Corp USD 1.99B 110M Dec/2025
Sonova Holding CHF 1.82B 216.8M Dec/2025
Supermax Corporation Bhd MYR 187.44M 18.13M Dec/2025
Veradigm USD 142.52M 9.38M Dec/2022
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025